Understanding OUR Cytokine-Based Immunotherapy Candidates Our Determination extends to advancing a robust portfolio of programs geared toward growing the horizons of cytokine-based immunotherapy, specifically for cancers where treatment options remain limited. Utilize the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline We https://financefeeds.com/occ-appoints-j-p-morgans-michael-kurd-to-board-of-directors/